News | May 24, 2024
Swixx Biopharma acquires Biopas to expand in Latin America
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
The company plans to add 1700 beds by FY27 through the organic route
Pharma Solutions operates 10 research and development and/or production sites globally
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
To accelerate the development of next-generation radioconjugates to treat cancer
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Subscribe To Our Newsletter & Stay Updated
